What does Dr. Schepers do?
DR. SCHEPERS specializes in the development and production of high-quality pharmaceutical products. The company focuses on innovative solutions for health care, aiming to improve patient outcomes through advanced therapies. With a commitment to research and quality, DR. SCHEPERS contributes significantly to the pharmaceutical industry.
- Signals
-
ProfitableProfitable € 721K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 4.88MStrong equity provides a buffer against setbacks.
Low riskLow risk 98.0%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 24.49A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 844KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 1.15MPositive EBITDA: operating activities are profitable.
- Investments
- Svp Dienstencentrum 32,85%, Apollonia - Knol 25%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
1.16M
|
€
1.12M
|
€
979K
|
€
948K
|
|
|
€
1.15M
|
€
1.11M
|
€
969K
|
€
930K
|
|
|
€
721K
|
€
717K
|
€
604K
|
€
586K
|
|
|
€
4.88M
|
€
4.37M
|
€
4.25M
|
€
3.65M
|
|
|
98.01%
|
97.16%
|
98.02%
|
98.72%
|
|
|
€
99K
|
€
128K
|
€
86K
|
€
47K
|
|
|
€
2.11M
|
€
1.61M
|
€
1.39M
|
€
670K
|
Publications 14
All publications- Kapitaal - Aandelen 02/02/2018
- Me. - Jaarrekening 31.12.2015, Ggk 02.03.2016, Ngl 31.08.2016 16512-0486-012 02/09/2016
- Me. - Jaarrekening 31.12.2014, Ggk 04.03.2015, Ngl 27.08.2015 15486-0523-012 01/09/2015
- Me. - Jaarrekening 31.12.2013, Ggk 05.03.2014, Ngl 22.08.2014 14444-0334-012 25/08/2014
- Kapitaal - Aandelen - Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) 21/01/2014
Frequently asked questions
Answers to the most common questions about Dr. Schepers, based on official government data and the filed annual accounts.
What is the VAT number of Dr. Schepers?
The VAT number of Dr. Schepers is BE0872.170.748.
When was Dr. Schepers established?
Dr. Schepers was founded in 28-02-2005.
What is the official address of Dr. Schepers?
The official address of Dr. Schepers is Henri Decleenestraat 29 Genk 3600.
What is the legal form of Dr. Schepers?
The juridical form of Dr. Schepers is Private limited company (BVBA/SPRL, legacy).
What is the annual revenue of Dr. Schepers?
The 2025 accounts of Dr. Schepers do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Dr. Schepers do?
DR. SCHEPERS specializes in the development and production of high-quality pharmaceutical products. The company focuses on innovative solutions for health care, aiming to improve patient outcomes through advanced therapies. With a commitment to research and quality, DR. SCHEPERS contributes significantly to the pharmaceutical industry.
Is Dr. Schepers a reliable company?
Dr. Schepers is a registered Rechtspersoon with company number 0872.170.748 and can be verified through the official CBE database.
What is the credit limit of Dr. Schepers?
The estimated credit limit of Dr. Schepers is €1,414,744.
Is Dr. Schepers still active?
Dr. Schepers currently has the status "Normal situation" and is active.